First Manhattan’s Outset Medical OM Stock Holding History

First Manhattan’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-240	Closed	-$195K	–	1593
2021 Q1	$195K	Hold	240	–	–	﹤0.01%	707
2020 Q4	$204K	Buy	+240	New	+$185K	﹤0.01%	664

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Manhattan's OM Position: Q2 2021 in Review

First Manhattan sold out of Outset Medical (OM) in Q2 2021, closing a stake of 240 shares — an estimated $195K sold.

First Manhattan first reported a position in OM in Q4 2020 and held it in 2 quarters. The position peaked at $204K in Q4 2020. 129 funds tracked by Wall St. Rank hold OM as of Q2 2021.

First Manhattan reported no remaining Outset Medical position as of Q2 2021 after selling out during the quarter.
First Manhattan sold 240 Outset Medical shares in Q2 2021, an estimated $195K.
First Manhattan first reported a position in Outset Medical in Q4 2020 and held it in 2 quarters.
First Manhattan's Outset Medical position peaked at $204K in Q4 2020.
129 funds tracked by Wall St. Rank held Outset Medical as of Q2 2021.

Based on First Manhattan's 13F filing for Q2 2021, filed 16 Aug 2021.